Subscribe To
Perkinelmer's (pki) latest launch to boost food analysis suite
PerkinElmer's (PKI) latest launch is likely to simplify the process of critical food analyses....
March 15, 2022, 1:33 pm
Biogen to present new research at the international conference on alzheimer's and parkinson's diseases (ad/pd 2022)
CAMBRIDGE, Mass., March 11, 2022 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced the company will present new Alzheimer's disease research, ...
March 11, 2022, 4:30 pm
Evelo biosciences' psoriasis candidate shows reductions in inflammatory cytokines
Evelo Biosciences Inc EVLO has announced the results of immunological biomarker analyses from its prev...
February 7, 2022, 7:54 am
Evelo biosciences' psoriasis candidate shows reductions in inflammatory cytokines
Evelo Biosciences Inc EVLO has announced the results of immunological biomarker analyses from its prev...
February 7, 2022, 7:54 am
Evelo biosciences' psoriasis candidate shows reductions in inflammatory cytokines
Evelo Biosciences Inc EVLO has announced the results of immunological biomarker analyses from its prev...
February 7, 2022, 7:54 am
Sarepta therapeutics' srp-9001 shows sustained functional improvements in multiple studies of patients with duchenne
CAMBRIDGE, Mass., Oct. 11, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseas...
October 11, 2021, 9:13 am
Sarepta therapeutics' srp-9001 shows sustained functional improvements in multiple studies of patients with duchenne
CAMBRIDGE, Mass., Oct. 11, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseas...
October 11, 2021, 9:13 am
Sarepta therapeutics' srp-9001 shows sustained functional improvements in multiple studies of patients with duchenne
CAMBRIDGE, Mass., Oct. 11, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseas...
October 11, 2021, 9:13 am